Key Takeaways
- A disrupted quarter, but margins held up: The FCI rice ban froze domestic ethanol execution for 8–10 weeks, yet gross margin still expanded ~2.2% in H1, driven largely by lower raw material costs.
- First US low-carbon ethanol order booked: A patent-protected solution for cutting carbon intensity in existing corn ethanol plants won its debut order, with eight more feasibility studies underway and IRA clarifications expected by end of Q3.
- CBG order book is building, slowly: One ₹100 crore order is under execution and the company remains L1 on another ₹400 crore, but the pace still hinges on land and feedstock tie-ups.
- GenX and pilots are on track for Q4: Commercial production at the new Mangalore facility and commissioning of SAF and PLA pilot plants are all slated for February–March 2024.
- What to watch next quarter: Whether the US Treasury delivers the promised IRA clarification, the pace of CBG order conversion from L1 to booked, and the ramp-up of H2 execution that management has reaffirmed.
Domestic Ethanol: The Q2 Disruption
- FCI rice ban froze activity: The ban on issuing rice to ethanol distilleries caused customers to halt ordering and banks to pause project funding. After OMCs raised grain-based ethanol rates, 8–10 weeks of the 12-week quarter were lost to start-stop-negotiation-clarification-restart cycles, hitting starchy-route projects hardest.
- Policy response was swift: The GST Council cut GST on molasses from 28% to 5%, and the upward revision of grain-based ethanol rates restored confidence. Management sees these quick actions as signalling unwavering government commitment to the EBP20 program.
- Feedstock shift underway: Rice dynamics have changed, with a shift taking place from rice-based plants to maize-based plants; maize is abundantly available. Sugar remains in surplus even after diverting all current capacity, so no feedstock problem exists on that route.
- H2 execution commitment stands: Management reaffirmed that H2 execution will be larger than H1, with no supply chain, manufacturing, vendor, or engineering constraints to prevent it.
Joshipura: "…start, stop, negotiation, clarification and restart almost eight to 10 weeks, 12 weeks quarter, you lose eight weeks on to the most significant section and as you are aware that over the previous period, a large section of the order booking on ethanol was coming through the Starchy route."
US & International Bioenergy
- First low-carbon ethanol order won: The order book includes a debut project to retrofit an existing US corn ethanol plant with Praj's technology to reduce its carbon intensity score, making the ethanol eligible as feedstock for SAF production. The solution is patent-protected and covered by an exclusivity agreement.
- IRA clarification is the gate: The low-carbon ethanol opportunity is moving slowly because the market awaits clarifications on certain provisions in the Inflation Reduction Act. Management expects that clarification from the US government by the end of Q3 FY24, and more orders may flow once it arrives.
- Eight projects in the pipeline: Detailed feasibility studies are either completed or underway across eight potential US cases, even as discussions continue.
- Europe and beyond on the horizon: Management expects the low-carbon ethanol business to move into Europe within a very short period, and into other markets as SAF production takes priority. The Global Biofuels Alliance platform, launched at the G20 with 19 countries and 12 international organizations, is expected to generate business from the global South and island nations over a three-to-five-year horizon.
- Competitive positioning is premium, not low-cost: On the first stage of carbon intensity reduction, management believes Praj has no equivalent competition; competitors Fluid Quip and ICM compete only on later stages. Praj positions itself explicitly as a best-in-class technology provider, not a low-cost solution provider.
Joshipura: "Our position in the United States market is not, it's actually not in any market for that matter- of a low-cost solution provider, we are very clearly saying we are best in class technology and therefore bat for me."
CBG: Orders Building, Pace Uncertain
- First project under execution: One CBG order worth ₹100 crore is now being executed, and the modus operandi for the balance five projects is being established with the customer.
- ₹400 crore sits at L1: As of 1st November, the company remains L1 on an additional ₹400 crore of CBG orders, but conversion timing is not assured.
- Ecosystem challenges are easing: OMCs are announcing projects and larger players are showing strong focus on establishing capacities, but the speed of build-out still depends on land availability and feedstock tie-ups.
- IRR is moving in the right direction: Management expects further positive developments on project IRR as technology develops and more projects are put on the ground, though it declined to give a specific IRR figure, citing varying customer cost of funds.
Margins: Raw Materials Did the Work
- Gross margin expanded despite a flat top line: H1 revenue was flattish, yet margin expanded ~2.2%, with 75–80% of the improvement coming from lower raw material prices and some upside from large-volume execution.
- Employee costs rose on schedule: The increase reflects the annual increment cycle starting in July and headcount additions for the new GenX facility; there is no one-off item.
- Other expenses up 25% in Q2: Management saw nothing extraordinary in the figure and attributed it to site-related expenses tied to execution, offering to follow up separately.
- Further expansion is possible, not promised: Management sees definite scope for margin improvement if export orders execute and raw material prices stay in a similar zone, but declined to commit to any specific percentage like 11%, 12%, or 15%.
Raole: "According to me around 75% to 80% is on account of raw material, because our execution is doing fine that we have seen some upside because of the large volume execution which we are doing, but measure contribution according to me is on account of raw material prices."
GenX, Pilots & New Business Lines
- GenX facility on track for Q4: Commercial production at the integrated manufacturing facility in Mangalore is expected to start in February–March 2024. Costs related to the setup are already sitting in employee cost and other expenses, but revenue has not yet begun to reflect.
- Enquiry pipeline gives confidence: Management described the GenX enquiry basket as "pretty big," which underpins the decision to start production in Q4, though it declined to quantify the basket.
- Two pilot plants nearing commissioning: One pilot for Sustainable Aviation Fuel (SAF) and one for PLA bio-plastics are being set up and are expected to commission in the last quarter of FY24. Business details will follow once the pilots demonstrate results.
- PHS segment has twin drivers: Ultra-high-purity water for semiconductor and green hydrogen applications, plus large fermentation-based capacities being set up in India where PHS's hygienic manufacturing strength combines with Praj's fermentation expertise.
- IOCL JV targeted for Q4 finalisation: Discussions are active on SAF and CBG fronts, but no specific project is finalised yet. The JV requires DIPAM and Niti Aayog approvals, and the process is underway at IOCL. Once formed, action on projects under SAF and CBG umbrellas is expected.
Joshipura: "We expect to commission this in the last quarter of the financial year. And once that is set up and we demonstrate then we will be able to be in a position to speak about the business that emanates out of that."
Order Book & Export Mix Shift
- Export share is rising meaningfully: The share of international business has increased over the last two to three quarters, and management aims to shift the export-to-domestic order ratio from the current 20:80 to at least 30:70 within two years, with the US as the largest contributor and Brazil next.
- Engineering revenue declined on cycle timing, not weakness: Engineering has its own 12–15 month execution cycle for ETCA segments. Recent orders have larger scope, requiring more engineering activity before manufacturing follows, so the decline is phasing rather than a demand signal.
- Retention money remains secure: No forfeiture of retention money has been seen to date; there can be delays in release but no forfeiture.
- Management declined to segment bioenergy orders: When asked to bifurcate domestic vs. exports within bioenergy, engineering, and HiPurity segments, management declined to provide the breakdown.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| H2 execution | H2 execution will be larger than H1 | H2 FY24 |
| US IRA clarification | Expected from US government; more orders may flow once received | By end of Q3 FY24 |
| GenX commercial production | Start of commercial production at Mangalore facility | Q4 FY24 (Feb–Mar) |
| GenX revenue | Revenue from Praj GenX to begin | Q4 FY24 |
| SAF pilot commissioning | Pilot plant to be commissioned | Q4 FY24 |
| PLA bio-plastics pilot commissioning | Pilot plant to be commissioned | Q4 FY24 |
| IOCL JV finalisation | JV to be firmed up, enabling action on SAF and CBG projects | By Q4 FY24 |
| Export ratio target | Shift from 20:80 to at least 30:70 export-to-domestic order ratio | Within two years |
| IOCL 2G plant performance | Two-stage program to establish plant performance | Next six months |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Consolidated income from operations | ₹882 cr |
| PBT | ₹84.81 cr, up 29% YoY from ₹65.78 cr |
| PAT | ₹62.37 cr, up from ₹48.13 cr in Q2 FY23 |
| H1 FY24 income from operations | ₹1,619 cr |
| H1 FY24 PBT | ₹162 cr, up from ₹120 cr in H1 FY23 |
| H1 FY24 PAT | ₹121 cr, up from ₹89.39 cr in H1 FY23 |
| H1 margin expansion | ~2.2% |
| Export revenue share | 16% of Q2 FY24 revenue |
| Revenue mix | 79% Bio-energy, 15% engineering, 6% PHS |
| Order intake | ₹1,063 cr, 71% domestic |
| Order intake mix | 68% Bio-Energy, 22% engineering, 10% PHS |
| Order backlog | ₹3,960 cr as of Sept 2023, 74% domestic |
| International order book share | 29% of total order book in Q2; H1 share 32% vs 13% in H1 FY22 |
| ETCA share in CPES order book | 52% |
| PHS order booking | Crossed ₹100 cr for the quarter |
| Cash in hand | ₹687 cr as of Sept 30, 2023 |
| CAPEX guidance for FY24 | ₹120 cr: ₹60 cr GenX, ₹20 cr routine, ₹40 cr pilot plants (SAF and PLA) |
| Services segment revenue | ₹10–15 cr out of total ₹880 cr |
| Current export-to-domestic order ratio | 20:80; target at least 30% international |